Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription 14.09.2026 1 Acta Derm Venereol 18 Allergy 15 Allergy Asthma Proc 2 Ann Allergy Asthma Immunol 3 Chest 8 Contact Dermatitis 4 Eur J Dermatol 1 Eur Respir J 2 Int Arch Allergy Immunol 1 J Allergy Clin Immunol 1 J Am Acad Dermatol 1 J Asthma 1 J Dermatol 3 J Invest Dermatol 1 PLoS Med 1 PLoS One 7 Respir Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Derm Venereol

1. THIANICH FC, Worgotter KM, Bruckner L, Grubler MR, et al
   The Efficacy of Different Treatment Options in Cutaneous Sarcoidosis: A Meta-analysis of RCTs.
   Acta Derm Venereol. 2026;106:0490.
   PubMed         Abstract available
   
   

   
   Allergy

2. KUMAR A, Chan R, Zounemat-Kermani N, Quek E, et al
   Small Airways Dysfunction and Remission in Adults With Asthma: A Longitudinal Exploratory Analysis of the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study.
   Allergy. 2026 Feb 18. doi: 10.1111/all.70264.
   PubMed         Abstract available
   
   
3. DECLERCQ J, Aegerter H, Smole U, Van Damme KFA, et al
   Chitin Is a Potent Inducer of Type 2 Airway Inflammation Independent of Endogenous Chitinolytic Activity.
   Allergy. 2026;81:3328-3344.
   PubMed         Abstract available
   
   
4. WEN H, Kole T, Carpaij OA, Karp T, et al
   Nasal Airway Transcriptome Reflects Selected Asthma-Associated Gene Signatures in the Lower Airways.
   Allergy. 2026 Mar 10. doi: 10.1111/all.70283.
   PubMed         Abstract available
   
   
5. ANDERSSON LI, Kupczyk M, Dahlen B, Izuhara K, et al
   Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity.
   Allergy. 2026 Apr 3. doi: 10.1111/all.70318.
   PubMed         Abstract available
   
   
6. SCHEIRE S, Lourijsen E, Blauwblomme M, Dib M, et al
   Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force.
   Allergy. 2026 Apr 21. doi: 10.1111/all.70332.
   PubMed         Abstract available
   
   
7. PATHINAYAKE PS, Brown AC, Awatade NT, Hansbro PM, et al
   Resolving Endoplasmic Reticulum-Protein Misfolding Restores Corticosteroid Sensitivity in Experimental Models of Severe Asthma.
   Allergy. 2026 Apr 26. doi: 10.1111/all.70353.
   PubMed         Abstract available
   
   
8. CANNATA AM, McAlees JW, Hargis JM, Shankar A, et al
   MAIT Cells Suppress IgE-Mediated Asthma via IFNgamma-Dependent B Cell Regulation.
   Allergy. 2026 May 7. doi: 10.1111/all.70384.
   PubMed         Abstract available
   
   
9. PYUNG YJ, Kang N, Chun J, Yu K, et al
   Metabolite-Based Endotypes of Asthma Reveal Distinct Clinical Characteristics and Immune Cell Signatures.
   Allergy. 2026 May 13. doi: 10.1111/all.70385.
   PubMed         Abstract available
   
   
10. GUNAYDIN FE, Marcassa G, Olivieri B, Senna G, et al
    Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related Evidence and Predictors.
    Allergy. 2026 May 14. doi: 10.1111/all.70388.
    PubMed         Abstract available
    
    
11. WECHSLER ME, Wenzel SE, Groshong SD, Castro M, et al
    Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma.
    Allergy. 2026 May 29. doi: 10.1111/all.70391.
    PubMed         Abstract available
    
    
12. SONG WJ, Kermani NZ, Versi A, Sanchez-Ovando S, et al
    Clinical Features of Cellular Senescence Pathways in Severe Asthma.
    Allergy. 2026 Jun 18. doi: 10.1111/all.70416.
    PubMed         Abstract available
    
    
13. YANG F, Seo S, Hasegawa T, Bloom CI, et al
    Longer Asthma Duration Is Associated With Elevated Non-T2 Sputum Biomarkers and Reduced T2 Inflammation in Severe Asthma.
    Allergy. 2026 Jul 9. doi: 10.1111/all.70436.
    PubMed         Abstract available
    
    
14. SHEN J, Chaudhuri R, Bicknell S, Mansur AH, et al
    The Airway Transcriptome in Type 2 Cytokine Biomarker-High and -Low Severe Asthma.
    Allergy. 2026 Jul 20. doi: 10.1111/all.70441.
    PubMed         Abstract available
    
    
15. CHAE W, An J, Lee CE, Kim SY, et al
    Plasma Metabolomes Identify Distinct Asthma Metabotypes: Findings From the COREA Cohort.
    Allergy. 2026 Aug 5. doi: 10.1111/all.70469.
    PubMed         Abstract available
    
    
16. GANGEMI S, Manti S, Virchow JC, Canonica GW, et al
    Targeting Airway Remodeling in Severe Asthma: Is There a Window of Opportunity for Biologic Therapy Predicting Effects Using Causal Artificial Intelligence?
    Allergy. 2026 Aug 27. doi: 10.1111/all.70468.
    PubMed         Abstract available
    
    
17. JIMENEZ-SAIZ R, Iborra S, Blanco C, Gonzalez-Perez R, et al
    Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases.
    Allergy. 2026 Sep 9. doi: 10.1111/all.70512.
    PubMed         Abstract available
    
    
18. SOUSA-PINTO B, Vieira RJ, Bognanni A, Klimek L, et al
    As-Needed Versus Regular Medication Use in the Treatment of Allergic Rhinitis in the Pollen Season: A MASK-air Study.
    Allergy. 2026 Sep 9. doi: 10.1111/all.70508.
    PubMed         Abstract available
    
    
19. GROSS L, Bariswyl L, Kupschke E, Wallimann A, et al
    Spatial Transcriptomics Identifies Characteristic Immunological Niches in Atopic Dermatitis.
    Allergy. 2026 Sep 11. doi: 10.1111/all.70513.
    PubMed         Abstract available
    
    

    
    Allergy Asthma Proc

20. ASLAN SAVAS S, Colkesen F, Gerek ME, Ergun UY, et al
    Determining the clinical impact of attack triggers in patients with hereditary angioedema.
    Allergy Asthma Proc. 2026;47:354-361.
    PubMed         Abstract available
    
    
21. ALTAS U, Cevik S, Alkaya H, Altas ZM, et al
    A biscotti-based milk and egg ladder using stepwise oral food challenges: A retrospective study in high-risk children.
    Allergy Asthma Proc. 2026;47:336-342.
    PubMed         Abstract available
    
    
22. FRIAS RUIZ C, Martin Martinez MD, Garcia de la Rosa G
    Cross-sensitization between Cannabis sativa and Lipid transfer proteins: Evidence from a large molecular cohort.
    Allergy Asthma Proc. 2026;47:e118-e124.
    PubMed         Abstract available
    
    
23. HARDIN H, Odin R, Bernstein JA
    Chronic autoimmune urticaria with worsening during the luteal phase suggestive of progesterone hypersensitivity successfully treated with rituximab.
    Allergy Asthma Proc. 2026;47:362-364.
    PubMed         Abstract available
    
    
24. KUZUCU FN, Genis C, Yorusun G, Sengul Emeksiz Z, et al
    Correlation between IMMULITE-measured grass panel specific immunoglobulin E levels and grass pollen skin-prick test reactivity in children.
    Allergy Asthma Proc. 2026;47:e98-e106.
    PubMed         Abstract available
    
    
25. BELLANTI JA, Settipane RA
    Communication, characterization, personalization, and clinical reasoning: The four pillars of modern allergy practice.
    Allergy Asthma Proc. 2026;47:315-318.
    PubMed        
    
    
26. 
    Abstracts presented at the Eastern Allergy Conference, May 28-31, 2026, Palm Beach, Florida.
    Allergy Asthma Proc. 2026;47:365-373.
    PubMed        
    
    
27. AFZAL SY, MacDougall MS, Lu D, McGhee SA, et al
    Evaluating the effect of age and comorbidity on dupilumab-dependent immunoglobulin E reduction in children with food allergy.
    Allergy Asthma Proc. 2026;47:328-335.
    PubMed         Abstract available
    
    
28. CANSUNAR RS, Erkoc Karaduman M, Cevirme L, Basir H, et al
    Hereditary angioedema in women: Hormonal and reproductive influences on disease activity.
    Allergy Asthma Proc. 2026;47:348-353.
    PubMed         Abstract available
    
    
29. YE F, Ni M, Liu Y, Li X, et al
    Unveiling four sensitization patterns among sensitized U.S. participants: Associations with allergic disease outcomes.
    Allergy Asthma Proc. 2026;47:e107-e117.
    PubMed         Abstract available
    
    
30. WU K, Li Y, Zhang Z, Wu D, et al
    Beyond immunoglobulin E (IgE): Novel roles of mas-related G protein-coupled receptor X2 (MRGPRX2) and protease-activated receptor 2 (PAR2) as nonhistaminergic pruriceptors in chronic spontaneous urticaria.
    Allergy Asthma Proc. 2026;47:e89-e97.
    PubMed         Abstract available
    
    
31. SEGAL CJ, Braunstein NG, Bensko JC, Bosso JV, et al
    Patient questions and artificial intelligence answers: Evaluating chatbots in aspirin-exacerbated respiratory disease.
    Allergy Asthma Proc. 2026;47:343-347.
    PubMed         Abstract available
    
    
32. ROBINSON K, Lugar P, Mullur J
    Penicillin allergy evaluation in pregnancy: Safety, efficacy, and antibiotic use outcomes.
    Allergy Asthma Proc. 2026;47:323-327.
    PubMed         Abstract available
    
    
33. HE KY, Wang W, Cheng P, Wang S, et al
    Early predictive value of postoperative fractional exhaled nitric oxide and peripheral eosinophil counts in patients with stable asthma undergoing general anesthesia.
    Allergy Asthma Proc. 2026;47:e73-e80.
    PubMed         Abstract available
    
    
34. BERGER WE
    Effective media communication in allergy and immunology: A practical framework for pediatric advocacy.
    Allergy Asthma Proc. 2026;47:319-322.
    PubMed         Abstract available
    
    

    
    Ann Allergy Asthma Immunol

35. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
    Corrigendum to 'Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection' [Annals of Allergy, Asthma & Immunology. Volumne 132, Issue 2 (2024), Pages 240-242].
    Ann Allergy Asthma Immunol. 2026 Sep 11:S1081-1206(26)00440.
    PubMed        
    
    
36. SZANIAWSKI MA, Jaramillo C, Feola P, Newman EN, et al
    De novo gelatin hypersensitivity following intraoperative Gelfoam exposure in two pediatric liver transplant recipients.
    Ann Allergy Asthma Immunol. 2026 Sep 12:S1081-1206(26)01178.
    PubMed        
    
    

    
    Chest

37. UNGPRASERT P, Keller SF, Culver DA
    Calcium and Vitamin D Supplements in Patients With Sarcoidosis.
    Chest. 2026;170:796-805.
    PubMed         Abstract available
    
    
38. WECHSLER ME, Quart B, Collazo R
    Eosinophil Counts in Adults with Asthma Treated with Anti-IL-4Ralpha Rademikibart: Exploratory Analyses in a Randomized Trial.
    Chest. 2026 Apr 28:S0012-3692(26)00563-5. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    
39. SANDHU E, Ragunayakam N, Mappanasingam AA, Friedlander Y, et al
    Dupilumab Reduces Mucus Radiodensity and New Plug Formation in Asthma.
    Chest. 2026 Apr 21:S0012-3692(26)00465-4. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    

    
    Contact Dermatitis

40. JENSEN MB, Ahlstrom MG, Jellesen MS, Nikpour S, et al
    Gold and Nickel Release From Gold-Plated Earrings Under Cysteine-Modified Artificial Sweat Conditions.
    Contact Dermatitis. 2026;95:380-385.
    PubMed         Abstract available
    
    
41. PEDERSEN MK, Schwensen JFB, Alfonso JH, Kirkeby CS, et al
    Methylchloroisothiazolinone and Methylisothiazolinone 10 Years After Regulation: A Case Story of Liquid Soaps and Shampoos.
    Contact Dermatitis. 2026;95:405-412.
    PubMed         Abstract available
    
    
42. BIZJAK-SURAN M, Marcun M, Kosnik M, Dinevski D, et al
    Patch Test Reactions to Dental Materials: A Retrospective Single-Centre Study.
    Contact Dermatitis. 2026;95:386-395.
    PubMed         Abstract available
    
    
43. LEE JJ, Jeong YS, Choi YW, Roh JY, et al
    AI-Assisted Automated Two-Stage Patch Test Interpretation System Using Vision Transformer.
    Contact Dermatitis. 2026;95:358-369.
    PubMed         Abstract available
    
    
44. BADAOUI A
    Multiple Allergic Contact Sensitizations to UVA Sunscreen Filters Including Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate (Mexoryl 400).
    Contact Dermatitis. 2026 Sep 7. doi: 10.1111/cod.70244.
    PubMed        
    
    
45. TOMASZEWSKI J, Posgai M, Quintero J
    Rouhani et al. 'Formaldehyde Emissions From 2-Octyl Cyanoacrylate: Quantified Risk for Allergic Contact Dermatitis'.
    Contact Dermatitis. 2026 Sep 8. doi: 10.1111/cod.70236.
    PubMed        
    
    
46. MOFID MM
    Reply to Formaldehyde Emissions From 2-Octyl Cyanoacrylate: Quantified Risk for Allergic Contact Dermatitis.
    Contact Dermatitis. 2026 Sep 8. doi: 10.1111/cod.70235.
    PubMed        
    
    
47. FENECH G, Langlois E, Pelletier E, Champmartin C, et al
    Occupational Allergic Contact Dermatitis From Over-Ear Headphones: Chemical Analysis Reveals Octylisothiazolinone and Other Potential Skin Sensitizers.
    Contact Dermatitis. 2026 Sep 10. doi: 10.1111/cod.70246.
    PubMed         Abstract available
    
    

    
    Eur J Dermatol

48. KOBAYASHI S, Ikuno Y, Shintani H, Yamada M, et al
    Amoxicillin delabelling in suspected clavulanate-selective delayed hypersensitivity: a case report using lymphocyte transformation and drug provocation tests.
    Eur J Dermatol. 2026;36:386-387.
    PubMed        
    
    
49. KITAOKA M, Hamaguchi Y, Nanpo H, Shimizu K, et al
    Mitotane-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome complicated with severe hepatitis.
    Eur J Dermatol. 2026;36:372-374.
    PubMed        
    
    
50. LAPI F, Marconi E, Rossi A, Cricelli I, et al
    Epidemiology update and refractoriness to initial pharmacotherapy of chronic spontaneous urticaria: insight from an Italian primary care cohort.
    Eur J Dermatol. 2026;36:353-361.
    PubMed         Abstract available
    
    
51. SHIBA M, Hagino T, Uchiyama A, Saeki H, et al
    Routine blood biomarkers associated with clinical response to tralokinumab in patients with atopic dermatitis: a 48-week real-world study in Japan.
    Eur J Dermatol. 2026;36:0.
    PubMed         Abstract available
    
    

    
    Eur Respir J

52. YAO P, Yang L, Liu D, He D, et al
    Distribution of blood eosinophil counts in the Chinese general population.
    Eur Respir J. 2026;68:2501570.
    PubMed         Abstract available
    
    

    
    Int Arch Allergy Immunol

53. ROJAS PEREZ-EZQUERRA P, Leton-Cabanillas P, Jover-Walsh A, Blanco-Lopez M, et al
    PENFAST-A: A Modified Clinical Decision Rule for ss-Lactam Allergy Risk Stratification in a Tertiary Allergy Center.
    Int Arch Allergy Immunol. 2026 Sep 5:1. doi: 10.1159.
    PubMed         Abstract available
    
    
54. SVENDSEN SV, Bindslev-Jensen C, Mortz CG
    Challenge-verified shrimp allergy in a Danish patient cohort throughout 23 years.
    Int Arch Allergy Immunol. 2026 Sep 11:1. doi: 10.1159.
    PubMed         Abstract available
    
    

    
    J Allergy Clin Immunol

55. BLUMENTHAL KG, Crawford RJ, King AJ, Khan DA, et al
    Reduced use of skin testing in the evaluation of antibiotic allergy in the United States.
    J Allergy Clin Immunol. 2026 Sep 9:S0091-6749(26)00593.
    PubMed        
    
    

    
    J Am Acad Dermatol

56. HAGINO T, Saeki H, Fujimoto E, Kanda N, et al
    Real-world effectiveness of upadacitinib for intrinsic versus extrinsic atopic dermatitis.
    J Am Acad Dermatol. 2026 Sep 11:S0190-9622(26)03516.
    PubMed        
    
    

    
    J Asthma

57. HOJ S, Meteran H
    Biologic-assisted house dust mite immunotherapy in allergic asthma: could it provide a bridge toward de-escalation?
    J Asthma. 2026 Sep 7:1-3. doi: 10.1080/02770903.2026.2730877.
    PubMed        
    
    

    
    J Dermatol

58. YE C, Gu X, Fei C, Zhou X, et al
    Hand Eczema Referred for Patch Testing: Retrospective Study in Shanghai, China From 2018 to 2023.
    J Dermatol. 2026;53:1342-1352.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

59. HUANG KR, Chang NW, Tai KY, Lin JD, et al
    Contact hypersensitivity promotes hair regeneration through SPP1-secreting macrophages.
    J Invest Dermatol. 2026 Sep 11:S0022-202X(26)02813.
    PubMed         Abstract available
    
    
60. BERNA-RICO E, Neria F, Gomez-de la Fuente E, Perez-Garcia B, et al
    Blood proteomics links systemic inflammation with early atherosclerosis in moderate-to-severe atopic dermatitis.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02743.
    PubMed         Abstract available
    
    
61. ASLANIAN FP, Halioua B, Tan J, Gu C, et al
    Real-Life Performance of the Dermatology Long-Term Life Impact Measure (DLLIM) in Atopic Dermatitis: An International Study of 15,450 Patients.
    J Invest Dermatol. 2026 Sep 9:S0022-202X(26)02748.
    PubMed        
    
    

    
    PLoS Med

62. ZHAKPAROV D, Lunjani N, Schmid M, Moriarty K, et al
    Multimodal protective and susceptibility clusters in paediatric atopic dermatitis: A machine learning-based, data-driven observational study.
    PLoS Med. 2026;23:e1004917.
    PubMed         Abstract available
    
    

    
    PLoS One

63. YANG B, Zhou G, Dai J
    A bioinformatic single-cell and structure-informed framework identifies a baicalin-CA2-keratinocyte state axis in atopic dermatitis.
    PLoS One. 2026;21:e0356174.
    PubMed         Abstract available
    
    

    
    Respir Med

64. MILGER K, Dorscheid D, Gessner C, Hilberg O, et al
    Early and continued asthma control up to week 24 in patients with severe, uncontrolled asthma treated with tezepelumab: Initial results of the real-world ASCENT study.
    Respir Med. 2026 Aug 6:109075. doi: 10.1016/j.rmed.2026.109075.
    PubMed         Abstract available
    
    
65. MARTINI M, Cecchi L, Musarra A, Jaubashi K, et al
    Expert consensus on the Management of Mild and Moderate Asthma.
    Respir Med. 2026 Aug 6:109078. doi: 10.1016/j.rmed.2026.109078.
    PubMed         Abstract available
    
    
66. ZHANG W, Chen W, Zhang Q
    The disease burden of ILD at the global, regional, and national levels from 1990 to 2021, and projections until 2035: Findings from the 2021 global burden of disease study with focus on China.
    Respir Med. 2026;262:109082.
    PubMed         Abstract available
    
    
67. VASSILEVA SM, Khamas SS, Dyhre-Petersen N, Principe S, et al
    The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients - a preliminary analysis.
    Respir Med. 2026;262:109067.
    PubMed         Abstract available
    
    
68. SINGH D, Poggesi I, Weng S, Slade D, et al
    Developing low-carbon metered-dose inhalers: effects of propellant HFA-152a on mucociliary clearance and bronchoconstriction in two Phase 1 randomised trials.
    Respir Med. 2026;262:109053.
    PubMed         Abstract available
    
    
69. SCICHILONE N, Genduso G, Bagnasco D, Barone A, et al
    Adherence To Inhaled Treatment Is Associated With Better Disease Control And Quality Of Life In Mild-To-Moderate Asthma.
    Respir Med. 2026 Aug 27:109127. doi: 10.1016/j.rmed.2026.109127.
    PubMed         Abstract available
    
    
70. CABOT J, Busquets X, Soriano JB
    Differential Diagnosis of Asthma and COPD: Established and Emerging Biomarkers and Technologies.
    Respir Med. 2026 Aug 28:109124. doi: 10.1016/j.rmed.2026.109124.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum